Ysabelle-S
Highly Vexatious
- Messages
- 524
This was posted today:
"Sir Simon Wessely is apparently still hawking cruises on a wrecked ship that can’t be salvaged. I urge refunds.
After a long career, Wessely is in the twilight of his influence and relevance. His tired defense of the design of the PACE trial suggests that he is out of touch with contemporary thinking about psychotherapy trials and risks to their validity. But his still inclined to chastise those who disagree with his assessment of the PACE trial.
I invite readers to read and decide…."
The rest here:
https://jcoynester.wordpress.com/20...rapy-trial-i-misunderstanding-control-groups/
He talks about Julie Rehmeyer's article and Wessely's remarks posted below. Then later says:
"This blog post is the first in a series. I will respond to some of Wessely’s odd pronouncements about evaluating clinical trials and his dismissive defense of the PACE trial."
Near the bottom of the post he says: "In my next blog post, I will take a critical look in a second comment on Julie’s article at Simon Wessely’s endorsement of outcomes switching as an admirable feature of the interpretation of clinical trials."
"Sir Simon Wessely is apparently still hawking cruises on a wrecked ship that can’t be salvaged. I urge refunds.
After a long career, Wessely is in the twilight of his influence and relevance. His tired defense of the design of the PACE trial suggests that he is out of touch with contemporary thinking about psychotherapy trials and risks to their validity. But his still inclined to chastise those who disagree with his assessment of the PACE trial.
I invite readers to read and decide…."
The rest here:
https://jcoynester.wordpress.com/20...rapy-trial-i-misunderstanding-control-groups/
He talks about Julie Rehmeyer's article and Wessely's remarks posted below. Then later says:
"This blog post is the first in a series. I will respond to some of Wessely’s odd pronouncements about evaluating clinical trials and his dismissive defense of the PACE trial."
Near the bottom of the post he says: "In my next blog post, I will take a critical look in a second comment on Julie’s article at Simon Wessely’s endorsement of outcomes switching as an admirable feature of the interpretation of clinical trials."
Last edited: